Enviomycin

Enviomycin
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	IM
ATC code	J04AB06 ( WHO );
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 3,6-diamino-N-[(3R,6Z)-3-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide;
CAS Number	33103-22-9 ;
PubChem CID	3032903 ;
DrugBank	DB08993 ;
ChemSpider	16736480 ;
UNII	XU299C23A2 ;
KEGG	D07897 ;
ChEMBL	ChEMBL2146142 ;
CompTox Dashboard (EPA)	DTXSID901027569 ;
Chemical and physical data
Formula	C25H43N13O10
Molar mass	685.700 g·mol−1
3D model (JSmol)	Interactive image ;
	SMILES C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC(=O)CC(C(CCN)O)N)N;
	InChI InChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/b13-7-/t10-,11-,12+,14+,15+,16-,18+/m1/s1 ; Key:HPWIIERXAFODPP-GHBBWTPBSA-N ;
	(what is this?) (verify)

Last updated January 03, 2026

Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus.^[1] It is used in the treatment of tuberculosis.^[2]

References

↑ Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732
↑ Selvakumar N, Kumar V, Acharyulu GS, Rehman F, Paramasivan CN, Prabhakar R (May 1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian Journal of Medical Research. 95: 101–4. PMID 1506058.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732

[2] Selvakumar N, Kumar V, Acharyulu GS, Rehman F, Paramasivan CN, Prabhakar R (May 1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian Journal of Medical Research. 95: 101–4. PMID 1506058.

[1]

[2]

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	IM
ATC code	J04AB06 ( WHO )
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 3,6-diamino-N-[(3R,6Z)-3-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide
CAS Number	33103-22-9 ^Y
PubChem CID	3032903
DrugBank	DB08993 ^N
ChemSpider	16736480 ^N
UNII	XU299C23A2
KEGG	D07897 ^Y
ChEMBL	ChEMBL2146142 ^N
CompTox Dashboard (EPA)	DTXSID901027569
Chemical and physical data
Formula	C₂₅H₄₃N₁₃O₁₀
Molar mass	685.700 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC(=O)CC(C(CCN)O)N)N
InChI InChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/b13-7-/t10-,11-,12+,14+,15+,16-,18+/m1/s1^N Key:HPWIIERXAFODPP-GHBBWTPBSA-N^N
^NY (what is this?) (verify)